OL-CD19-GDT
/ Overland Therapeutics
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
September 12, 2025
A Study of OL-CD19-GDT in Relapsed/ Refractory Autoimmune Diseases
(clinicaltrials.gov)
- P1 | N=44 | Recruiting | Sponsor: Beijing GoBroad Hospital
New P1 trial • Immunology • Scleroderma • Systemic Sclerosis
1 to 1
Of
1
Go to page
1